在初治的慢性乙型肝炎中国患者中，乙肝病毒不存在rtA194T突变，该突变会导致对替诺福韦的敏感性降低。 - Suppr

Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility.

作者信息

Liu Yan, Wang Chun-mei, Cheng Jun, Liang Zhao-ling, Zhong Yan-wei, Ren Xiao-qiang, Xu Zhi-hui, Zoulim Fabien, Xu Dong-ping

机构信息

Viral Hepatitis Research Laboratory, Institute of Infectious Diseases, Beijing 302 Hospital, Beijing 100039, China.

出版信息

Chin Med J (Engl). 2009 Jul 5;122(13):1585-6.

PMID:19719953

Abstract

摘要

相似文献

Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility.

Chin Med J (Engl). 2009 Jul 5;122(13):1585-6.

Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.

Antivir Ther. 2008;13(3):341-8.

[Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].

MMW Fortschr Med. 2009 May 28;151(22):38-9.

Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.

AIDS. 2009 Jan 14;23(2):268-72. doi: 10.1097/QAD.0b013e3283224316.

Tenofovir for treatment of hepatitis B virus reactivation in patients with chronic GVHD.

Bone Marrow Transplant. 2011 Sep;46(9):1274-5. doi: 10.1038/bmt.2010.290. Epub 2010 Dec 13.

Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication.

Hepatology. 2002 Aug;36(2):507-8. doi: 10.1053/jhep.2002.35328.

Tenofovir salvage for nucleoside experienced patients: muddy waters?

Gut. 2011 Feb;60(2):148-50. doi: 10.1136/gut.2010.229062.

Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients.

Antivir Ther. 2009;14(5):649-54.

Selection of K65R mutation in HIV-2-infected patients receiving tenofovir-containing regimen.

Antivir Ther. 2004 Aug;9(4):635-6.

Potency of tenofovir in chronic hepatitis B: mono or combination therapy?

J Hepatol. 2008 Mar;48(3):383-6. doi: 10.1016/j.jhep.2007.12.006. Epub 2007 Dec 31.

引用本文的文献

Phylogenetic Analysis and Emerging Drug Resistance against Different Nucleoside Analogues in Hepatitis B Virus Positive Patients.

Microorganisms. 2023 Oct 24;11(11):2622. doi: 10.3390/microorganisms11112622.

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients.

Front Immunol. 2023 Aug 14;14:1211980. doi: 10.3389/fimmu.2023.1211980. eCollection 2023.

Molecular detection of hepatitis B virus genotype E with immune escape mutations in chronic hepatitis B patients on long-term antiviral therapy in Jos, Nigeria.

Afr J Lab Med. 2022 Oct 18;11(1):1677. doi: 10.4102/ajlm.v11i1.1677. eCollection 2022.

Hepatitis B virus DNA polymerase gene polymorphism based prediction of genotypes in chronic HBV patients from Western India.

Afr Health Sci. 2017 Sep;17(3):762-772. doi: 10.4314/ahs.v17i3.19.

Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study.

Chin Med J (Engl). 2017 Apr 20;130(8):914-919. doi: 10.4103/0366-6999.204107.

Association between hepatitis B virus basal core promoter/precore region mutations and the risk of hepatitis B-related acute-on-chronic liver failure in the Chinese population: an updated meta-analysis.

Hepatol Int. 2016 Jul;10(4):606-15. doi: 10.1007/s12072-016-9716-7. Epub 2016 Mar 16.

Detection and analysis of resistance mutations of hepatitis B virus.

Int J Clin Exp Med. 2015 Jun 15;8(6):9630-9. eCollection 2015.

Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?

BMC Infect Dis. 2013 Nov 6;13:524. doi: 10.1186/1471-2334-13-524.

Profile of hepatitis B virus resistance mutations against nucleoside/nucleotide analogue treatment in Chinese patients with chronic hepatitis B.

Virol J. 2013 Oct 25;10:313. doi: 10.1186/1743-422X-10-313.

Hepatitis B virus (HBV) subgenotypes C2 and B2 differ in lamivudine- and adefovir-resistance-associated mutational patterns in HBV-infected Chinese patients.

J Clin Microbiol. 2010 Dec;48(12):4363-9. doi: 10.1128/JCM.01518-10. Epub 2010 Sep 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility.

作者信息

Liu Yan, Wang Chun-mei, Cheng Jun, Liang Zhao-ling, Zhong Yan-wei, Ren Xiao-qiang, Xu Zhi-hui, Zoulim Fabien, Xu Dong-ping

机构信息

Viral Hepatitis Research Laboratory, Institute of Infectious Diseases, Beijing 302 Hospital, Beijing 100039, China.

出版信息

Chin Med J (Engl). 2009 Jul 5;122(13):1585-6.

PMID:19719953

Abstract

摘要

Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility.

作者信息

机构信息

出版信息

相似文献

引用本文的文献